메뉴 건너뛰기




Volumn 69, Issue 12, 2014, Pages 1629-1638

A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol

Author keywords

Allergic rhinoconjunctivitis; Cluster immunotherapy; Glutardialdehyde polymerized allergen extract; Grass pollen; Specific subcutaneous immunotherapy

Indexed keywords

GLUTARALDEHYDE; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN G4; PLACEBO; POLYMER; ALLERGEN; PLANT EXTRACT;

EID: 84909594983     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12513     Document Type: Article
Times cited : (36)

References (47)
  • 3
    • 40549093007 scopus 로고    scopus 로고
    • Allergic rhinitis and its impact on asthma (ARIA) 2008 update
    • in collaboration with the World Health Organization, GA(2)LEN and Aller-Gen
    • Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and Aller-Gen). Allergy 2008;63(Suppl. 86):8-160.
    • (2008) Allergy , vol.63 , pp. 8-160
    • Bousquet, J.1    Khaltaev, N.2    Cruz, A.A.3    Denburg, J.4    Fokkens, W.J.5    Togias, A.6
  • 4
    • 50249230114 scopus 로고
    • Prophylactic inoculations against hay fever
    • Noon L. Prophylactic inoculations against hay fever. Lancet 1911;1:1572-1573.
    • (1911) Lancet , vol.1 , pp. 1572-1573
    • Noon, L.1
  • 5
    • 0031817107 scopus 로고    scopus 로고
    • WHO position paper: Allergen immunotherapy: Therapeutic vaccines for allergic diseases
    • Bousquet J, Lockey RF, Malling HJ. WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42.
    • (1998) Allergy , vol.53 , pp. 1-42
    • Bousquet, J.1    Lockey, R.F.2    Malling, H.J.3
  • 6
    • 84863970198 scopus 로고    scopus 로고
    • Subcutaneous allergen immunotherapy for allergic disease: Examining efficacy, safety and cost-effectiveness of current and novel formulations
    • Cox L, Calderon M, Pfaar O. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy 2012;6:1-16.
    • (2012) Immunotherapy , vol.6 , pp. 1-16
    • Cox, L.1    Calderon, M.2    Pfaar, O.3
  • 7
    • 58149460764 scopus 로고    scopus 로고
    • Adverse effects and fatalities associated with subcutaneous allergen immunotherapy
    • Bukantz SC, Bagg AS, Lockey RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clin Allergy Immunol 2008;21:455-468.
    • (2008) Clin Allergy Immunol , vol.21 , pp. 455-468
    • Bukantz, S.C.1    Bagg, A.S.2    Lockey, R.F.3
  • 9
    • 0014988001 scopus 로고
    • Preparation and properties of allergoids, derived from native pollen allergens by mild formalin treatment
    • Marsh DG. Preparation and properties of allergoids, derived from native pollen allergens by mild formalin treatment. Int Arch Allergy Appl Immunol 1971;41:199-215.
    • (1971) Int Arch Allergy Appl Immunol , vol.41 , pp. 199-215
    • Marsh, D.G.1
  • 10
    • 33747640551 scopus 로고    scopus 로고
    • Accelerated immunotherapy schedules: Review of efficacy and safety
    • Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol 2006;97:126-137.
    • (2006) Ann Allergy Asthma Immunol , vol.97 , pp. 126-137
    • Cox, L.1
  • 14
    • 21344467468 scopus 로고    scopus 로고
    • Doubleblind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus
    • Tabar AI, Echechipia S, Garcia BE, Olaguibel JM, Lizaso MT, Gomez B et al. Doubleblind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-118.
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 109-118
    • Tabar, A.I.1    Echechipia, S.2    Garcia, B.E.3    Olaguibel, J.M.4    Lizaso, M.T.5    Gomez, B.6
  • 15
    • 31744434189 scopus 로고    scopus 로고
    • Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts
    • Casanovas M, Martin R, Jimenez C, Caballero R, Fernández-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol 2006;139:153-158.
    • (2006) Int Arch Allergy Immunol , vol.139 , pp. 153-158
    • Casanovas, M.1    Martin, R.2    Jimenez, C.3    Caballero, R.4    Fernández-Caldas, E.5
  • 16
    • 44249114563 scopus 로고    scopus 로고
    • Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment
    • Subiza J, Feliú A, Subiza JL, Uhlig J, Fernández-Caldas E. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy 2008;38:987-994.
    • (2008) Clin Exp Allergy , vol.38 , pp. 987-994
    • Subiza, J.1    Feliú, A.2    Subiza, J.L.3    Uhlig, J.4    Fernández-Caldas, E.5
  • 17
    • 63349083457 scopus 로고    scopus 로고
    • Safety of two Cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens
    • Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno AC et al. Safety of two Cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Int Arch Allergy Immunol 2009;150:102-108.
    • (2009) Int Arch Allergy Immunol , vol.150 , pp. 102-108
    • Pfaar, O.1    Klimek, L.2    Fischer, I.3    Sieber, J.4    Amoroso, S.5    Moreno, A.C.6
  • 18
    • 53449090330 scopus 로고    scopus 로고
    • Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy
    • Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J et al. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy. Int Arch Allergy Immunol 2009;148:251-260.
    • (2009) Int Arch Allergy Immunol , vol.148 , pp. 251-260
    • Schubert, R.1    Eickmeier, O.2    Garn, H.3    Baer, P.C.4    Mueller, T.5    Schulze, J.6
  • 19
    • 51849164024 scopus 로고    scopus 로고
    • Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis
    • Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J. Comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Int Arch Allergy Immunol 2009;148:161-169.
    • (2009) Int Arch Allergy Immunol , vol.148 , pp. 161-169
    • Zhang, L.1    Wang, C.2    Han, D.3    Wang, X.4    Zhao, Y.5    Liu, J.6
  • 20
    • 73649084776 scopus 로고    scopus 로고
    • Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis
    • Pfaar O, Mösges R, Hörmann K, Klimek L. Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis. Eur Arch Otorhinolaryngol 2010;267:245-250.
    • (2010) Eur Arch Otorhinolaryngol , vol.267 , pp. 245-250
    • Pfaar, O.1    Mösges, R.2    Hörmann, K.3    Klimek, L.4
  • 21
    • 84855791137 scopus 로고    scopus 로고
    • A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy
    • Pfaar O, Urry Z, Robinson DS, Sager A, Richards D, Hawrylowicz CM et al. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy 2012;67:272-279.
    • (2012) Allergy , vol.67 , pp. 272-279
    • Pfaar, O.1    Urry, Z.2    Robinson, D.S.3    Sager, A.4    Richards, D.5    Hawrylowicz, C.M.6
  • 26
    • 33846964159 scopus 로고    scopus 로고
    • Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
    • Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317-324.
    • (2007) Allergy , vol.62 , pp. 317-324
    • Canonica, G.W.1    Baena-Cagnani, C.E.2    Bousquet, J.3    Bousquet, P.J.4    Lockey, R.F.5    Malling, H.J.6
  • 28
    • 34547665695 scopus 로고    scopus 로고
    • Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials
    • Clark J, Shall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy 2007;62:1023-1028.
    • (2007) Allergy , vol.62 , pp. 1023-1028
    • Clark, J.1    Shall, R.2
  • 29
    • 77649313243 scopus 로고    scopus 로고
    • Klinische parameter zur Beurteilung der Wirksamkeit einer spezifischen Immuntherapie bei polleninduzierter Rhinitis allergica. Bestimmung von "well days" als ergänzendes Konzept
    • Vorwalder S, Pfaar O, Klimek L. Klinische parameter zur Beurteilung der Wirksamkeit einer spezifischen Immuntherapie bei polleninduzierter Rhinitis allergica. Bestimmung von "well days" als ergänzendes Konzept. Allergologie 2010;33:35-42.
    • (2010) Allergologie , vol.33 , pp. 35-42
    • Vorwalder, S.1    Pfaar, O.2    Klimek, L.3
  • 30
    • 36248986032 scopus 로고    scopus 로고
    • Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
    • Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-1345.
    • (2007) J Allergy Clin Immunol , vol.120 , pp. 1338-1345
    • Didier, A.1    Malling, H.J.2    Worm, M.3    Horak, F.4    Jäger, S.5    Montagut, A.6
  • 31
    • 0037358612 scopus 로고    scopus 로고
    • Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology
    • Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW et al. Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology. Laryngorhinootologie 2003;82:183-188.
    • (2003) Laryngorhinootologie , vol.82 , pp. 183-188
    • Riechelmann, H.1    Bachert, C.2    Goldschmidt, O.3    Hauswald, B.4    Klimek, L.5    Schlenter, W.W.6
  • 32
    • 0002457760 scopus 로고
    • Immunotherapy. Position paper of the European Academy of Allergology and Clinical Immunotherapy
    • Malling HJ, Weeke B. Immunotherapy. Position paper of the European Academy of Allergology and Clinical Immunotherapy. Allergy 1993;48:7-35.
    • (1993) Allergy , vol.48 , pp. 7-35
    • Malling, H.J.1    Weeke, B.2
  • 34
    • 0025882782 scopus 로고
    • Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
    • Lehmacher W, Wassmer G, Reitmeir P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991;47:511-521.
    • (1991) Biometrics , vol.47 , pp. 511-521
    • Lehmacher, W.1    Wassmer, G.2    Reitmeir, P.3
  • 35
    • 68049134476 scopus 로고    scopus 로고
    • The problem of placebo-controlled trials allowing rescue medication: How to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment
    • Vent J, Lehmacher W. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment. Curr Opin Allergy Clin Immunol 2009;9:222-227.
    • (2009) Curr Opin Allergy Clin Immunol , vol.9 , pp. 222-227
    • Vent, J.1    Lehmacher, W.2
  • 37
    • 84902083555 scopus 로고    scopus 로고
    • Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: An EAACI Position Paper
    • Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014;69:854-867.
    • (2014) Allergy , vol.69 , pp. 854-867
    • Pfaar, O.1    Demoly, P.2    Gerth Van Wijk, R.3    Bonini, S.4    Bousquet, J.5    Canonica, G.W.6
  • 38
    • 0034995781 scopus 로고    scopus 로고
    • A well-tolerated grass pollenspecific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
    • Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollenspecific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001;56:498-505.
    • (2001) Allergy , vol.56 , pp. 498-505
    • Drachenberg, K.J.1    Wheeler, A.W.2    Stuebner, P.3    Horak, F.4
  • 40
    • 20044371042 scopus 로고    scopus 로고
    • Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid
    • Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005;60:801-807.
    • (2005) Allergy , vol.60 , pp. 801-807
    • Corrigan, C.J.1    Kettner, J.2    Doemer, C.3    Cromwell, O.4    Narkus, A.5
  • 41
    • 58149117614 scopus 로고    scopus 로고
    • Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
    • Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167-173.
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 167-173
    • Bufe, A.1    Eberle, P.2    Franke-Beckmann, E.3    Funck, J.4    Kimmig, M.5    Klimek, L.6
  • 42
    • 79955444722 scopus 로고    scopus 로고
    • Allergen-specific immunotherapy: Which outcome measures are useful in monitoring clinical trials?
    • Pfaar O, Kleine-Tebbe J, Hörmann K, Klimek L. Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? Immunol Allergy Clin North Am 2011;31:289-309.
    • (2011) Immunol Allergy Clin North Am , vol.31 , pp. 289-309
    • Pfaar, O.1    Kleine-Tebbe, J.2    Hörmann, K.3    Klimek, L.4
  • 43
    • 84860786206 scopus 로고    scopus 로고
    • Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials
    • Calderon MA, Eichel A, Makatsori M, Pfaar O. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials. Curr Opin Allergy Clin Immunol 2012;12:249-256.
    • (2012) Curr Opin Allergy Clin Immunol , vol.12 , pp. 249-256
    • Calderon, M.A.1    Eichel, A.2    Makatsori, M.3    Pfaar, O.4
  • 44
    • 34047163404 scopus 로고    scopus 로고
    • Mechanisms of allergen-specific immunotherapy
    • Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-789.
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 780-789
    • Akdis, M.1    Akdis, C.A.2
  • 45
    • 80051734103 scopus 로고    scopus 로고
    • Mechanisms of immunotherapy to aeroallergens
    • Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy 2011;41:1235-1246.
    • (2011) Clin Exp Allergy , vol.41 , pp. 1235-1246
    • Shamji, M.H.1    Durham, S.R.2
  • 46
    • 79955441842 scopus 로고    scopus 로고
    • Serum immunologic markers for monitoring allergen-specific immunotherapy
    • Shamji MH, James LK, Durham SR. Serum immunologic markers for monitoring allergen-specific immunotherapy. Immunol Allergy Clin North Am 2011;31:311-323.
    • (2011) Immunol Allergy Clin North Am , vol.31 , pp. 311-323
    • Shamji, M.H.1    James, L.K.2    Durham, S.R.3
  • 47
    • 78349299047 scopus 로고    scopus 로고
    • Immunotherapy with depigmented-polymerized mixed tree pollen extract: A clinical trial and responder analysis
    • Pfaar O, Robinson DS, Sager A, Emuzyte R. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy 2010;65:1614-1621.
    • (2010) Allergy , vol.65 , pp. 1614-1621
    • Pfaar, O.1    Robinson, D.S.2    Sager, A.3    Emuzyte, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.